Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HaploX Global logo — HaploX specializes in genetic testing solutions, gene sequen...

HaploX Global

HaploX specializes in genetic testing solutions, gene sequencing, liquid biopsy, bioinformatics, and big data analysis.

Founded 2014 Hong Kong S.a.r. Hong Kong S.a.r. 14 employees Series D Total: $72.19M Biotechnology, Health Care

General Information

Company Name HaploX Global
Founded Year 2014
Location Hong Kong S.a.r. Hong Kong S.a.r. +1
Employees 14
Industries Biotechnology, Health Care
Funding Stage Series D
Social

Get notified when HaploX Global moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HaploX Global

is a biotechnology company founded in 2014. The company's focus lies in enhancing cancer patient care through advanced liquid biopsy techniques and AI-driven data analysis. HaploX offers a range of tools, including those for DNA extraction and amplification from liquid samples, tagged sequencing, and the management and analysis of resulting data. The latest investment in the company was a Series D investment on 26 July 2022, with funding from SBCVC and CNCB Capital. HaploX Biotechnology operates within the healthcare industry.

Taxonomy: Liquid Biopsy, Gene Sequencing, Big Data Analysis, Cancer Patient Care, Advanced Technology, Precision Medicine, Genomic Data, Tumor Detection, Tumor Diagnosis, Tumor Prognosis, Personalized Therapy, Ultra-low DNA Concentration

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 2
Investor Investor
26 Jul 2022
Series B •••••• 1
Investor
28 Jun 2018
Series A •••••• 3
Investor Investor Investor
29 Dec 2017
Series A •••••• 1
Investor
01 Jan 2016

HaploX Global Alternatives & Competitors

HaploX Global vs
Yikon Genomics
Yikon Genomics China

Innovate for The Health of Billions

Series D
55 employees
Biotechnology
HaploX Global vs
Wellness Labs
Wellness Labs United States

Fast service. Accurate testing. Quality results.

26 employees
Health Care
HaploX Global vs
Gene+
Gene+ China

Omics for better health

Series B
92 employees
Biotechnology
Compare HaploX Global vs Gene+

FAQ About HaploX Global

HaploX specializes in genetic testing solutions, gene sequencing, liquid biopsy, bioinformatics, and big data analysis.
HaploX Global was founded in 2014.
HaploX Global is headquartered in Hong Kong S.a.r..
HaploX Global operates in the following industries: Biotechnology, Health Care.
HaploX Global has approximately 14 employees.
HaploX Global has completed 4 funding rounds, raising a total of $72.19M. The latest funding stage is Series D.
Top alternatives and competitors to HaploX Global include Yikon Genomics, Wellness Labs, Gene+, Zalma Ltd., CGC Genetics / CGC Centro Genetica Clinica. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HaploX Global and Yikon Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HaploX Global and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy